货号:A580119
同义名:
1.alpha.-Hydroxyvitamin D2; 1-hydroxy Vitamin D2
Doxercalciferol 是一种合成的维生素 D2 类似物,可抑制甲状旁腺激素的合成与分泌,适用于继发性甲状旁腺功能亢进及代谢性骨病的研究。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Doxercalciferol (DOX) is a Vitamin D2 analog, acts as an activator of Vitamin D receptor, and prevent renal disease. DOX had a beneficial effect on age-related bone deteriorations in aging mice by promoting osteoblast activity and cartilage regeneration and inhibiting osteoclast-specific genes expression[3]. Doxercalciferol (0.083, 0.167 or 0.333 μg/kg, i.p.) elevates serum phosphorus at Week 6 in 5/6 nephrectomized (NX) rats. Doxercalciferol (0.167 and 0.333 μg/kg) also increases serum calcium and Ca × P at Weeks 2 and 6, and enhances increased pulse wave velocity (PWV) at Week 6 in 5/6 nephrectomized (NX) rats. Doxercalciferol blocks PTH from rising at 0.083 μg/kg, and lowers serum PTH to the SHAM level[4]. Doxercalciferol was administered intraperitoneally at 150 ng, 3 times per week (Monday, Wednesday, Friday) for 6 weeks. Rats on HS diet with doxercalciferol administration had significant decrease in cardiac hypertrophy and improved cardiac function compared to the HS + vehicle. In addition, there was a significant decrease in plasma brain natriuretic peptide (BNP) level and tissue atrial natriuretic factor (ANF) mRNA level with doxercalciferol treatment. Doxercalciferol also significantly reduced the level of protein kinase C-α (PKCα)[5]. Doxercalciferol (125 ng/kg, i.p. thrice per week) increases expression of VDR mRNA level and renal expression of TRPV5 in NON mice fed a HF diet. Doxercalciferol also improves proteinuria, prevents loss of podocytes, and accumulation of extracellular matrix proteins in HF diet-induced mice[6]. |
| Concentration | Treated Time | Description | References | |
| Huh7 cells | 1.98 ± 1.30 μmol/L (EC50) | 6 days | To evaluate the inhibitory effect of Doxercalciferol on SFTSV-induced cytopathic effect (CPE), results showed dose-dependent protection against CPE. | Virol Sin. 2024 Oct;39(5):802-811. |
| N2a wt cells | 100 nM | 18 hours | Doxercalciferol significantly increased Aβ degradation to 158.2%. | Int J Mol Sci. 2017 Dec 19;18(12):2764. |
| SH-SY5Y wt cells | 100 nM | 24 hours | Doxercalciferol significantly reduced β-secretase activity to 77.3%. | Int J Mol Sci. 2017 Dec 19;18(12):2764. |
| SH-SY5Y APP695 overexpressing cells | 100 nM | 24 hours | Doxercalciferol significantly reduced total Aβ level to 70.9%. | Int J Mol Sci. 2017 Dec 19;18(12):2764. |
| Administration | Dosage | Frequency | Description | References | ||
| ICR suckling mice | Lethal SFTSV infection model | Intraperitoneal injection | 0.3 or 0.15 μg/kg | Daily for 8 days | To evaluate the therapeutic effect of Doxercalciferol on SFTSV-infected ICR suckling mice, results showed increased survival rates (40% protection). | Virol Sin. 2024 Oct;39(5):802-811. |
| LHβ-Tag transgenic mice | Transgenic retinoblastoma model | Oral gavage | 0.1, 0.3, 0.5, or 1.0 µg/day | Five times per week for 5 weeks | To determine the effectiveness of 1α-OH-D2 in inhibiting retinoblastoma and evaluate its toxicity. Results showed significantly smaller tumor areas in all treatment groups compared to controls (P <.02), but no dose-dependent response curve. Higher mortality was observed in the 0.5 and 1.0 μg groups (P <.01). | Trans Am Ophthalmol Soc. 2002;100:125-9 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01717989 | - | Completed | - | - | |
| NCT01717989 | - | Completed | - | - | |
| NCT01181531 | - | Completed | - | - | |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.42mL 0.48mL 0.24mL |
12.12mL 2.42mL 1.21mL |
24.23mL 4.85mL 2.42mL |
|
| CAS号 | 54573-75-0 |
| 分子式 | C28H44O2 |
| 分子量 | 412.65 |
| SMILES Code | C=C1[C@H](C[C@@H](C/C1=C/C=C2[C@]3([C@@](C)([C@H](CC3)[C@@H](/C=C/[C@@H](C(C)C)C)C)CCC/2)[H])O)O |
| MDL No. | MFCD00871065 |
| 别名 | 1.alpha.-Hydroxyvitamin D2; 1-hydroxy Vitamin D2; Doxercalciferol. 1-hydroxy Vitamin D2; TSA 840; 1-Hydroxyergocalciferol; Hectorol; 1α-hydroxyvitamin D2 |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C |
| 溶解方案 |
DMSO: 105 mg/mL(254.45 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1